You have 9 free searches left this month | for more free features.

vismodegib

Showing 26 - 50 of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)

Active, not recruiting
  • Cancer of Unknown Primary Site
  • Blacktown, New South Wales, Australia
  • +140 more
Jan 6, 2023

Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma Trial in United States (drug, biological, other)

Completed
  • Extensive Stage Small Cell Lung Carcinoma
  • Recurrent Small Cell Lung Carcinoma
  • Scottsdale, Arizona
  • +300 more
Dec 10, 2020

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Prostate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7 Trial in United States (Goserelin

Terminated
  • Prostate Adenocarcinoma
  • +2 more
  • Goserelin Acetate
  • +3 more
  • Ann Arbor, Michigan
  • +4 more
Feb 6, 2019

Basal Cell Carcinoma Trial in Tucson (Vismodegib)

Completed
  • Basal Cell Carcinoma
  • Vismodegib
  • Tucson, Arizona
    Arizona Cancer Center
Jul 17, 2018

Prostate Cancer Trial in Baltimore (Vismodegib)

Completed
  • Prostate Cancer
  • Vismodegib
  • Baltimore, Maryland
    Johns Hopkins Hospital
Oct 5, 2017

Basal Cell Carcinoma Trial in Worldwide (vismodegib)

Completed
  • Basal Cell Carcinoma
  • vismodegib
  • Buenos Aires, Argentina
  • +180 more
Mar 4, 2019

Myelofibrosis Trial in Worldwide (Placebo, Ruxolitinib, Vismodegib)

Completed
  • Myelofibrosis
  • Placebo
  • +2 more
  • Fort Myers, Florida
  • +12 more
May 4, 2018

Breast Cancer Trial in Pamplona (vismodegib, Paclitaxel, Epirubicin)

Unknown status
  • Breast Cancer
  • vismodegib
  • +3 more
  • Pamplona, Navarra, Spain
    ClĂ­nica Universidad de Navarra
Oct 23, 2017

Idiopathic Pulmonary Fibrosis Trial in Germany, United States (Pirfenidone, Vismodegib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • La Jolla, California
  • +14 more
Oct 26, 2017

Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer Trial in Ann Arbor (Gemcitabine Hydrochloride, Laboratory Biomarker

Completed
  • Recurrent Pancreatic Carcinoma
  • Stage IV Pancreatic Cancer
  • Gemcitabine Hydrochloride
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Aug 2, 2017

Malignant Tumor Trial in Chicago (Pharmacological Study, Vismodegib)

Completed
  • Malignant Neoplasm
  • Pharmacological Study
  • Vismodegib
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 11, 2017

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Basal Cell Carcinoma Trial in Worldwide (Vismodegib, Placebo)

Completed
  • Basal Cell Carcinoma
  • Vismodegib
  • Placebo
  • Los Angeles, California
  • +57 more
Aug 30, 2017

Diffuse Large B-cell Lymphoma, Indolent Non-hodgkin Lymphoma, Primary CNS Lymphoma Trial in France (Vismodegib)

Terminated
  • Diffuse Large B-cell Lymphoma
  • +3 more
  • Vismodegib
  • Creteil, France
  • +9 more
Mar 8, 2017

Basal Cell Carcinoma Trial in United States (Placebo, Vismodegib)

Terminated
  • Basal Cell Carcinoma
  • Placebo
  • Vismodegib
  • Scottsdale, Arizona
  • +20 more
Mar 27, 2017

Acute Myeloid Leukemia Trial in Montreal (Ribavirin, Vismodegib, Decitabine)

Unknown status
  • Acute Myeloid Leukemia
  • Montreal, Quebec, Canada
    Jewish General Hospital
Mar 6, 2017

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (drug, procedure, other)

Completed
  • Adult Giant Cell Glioblastoma
  • +3 more
  • vismodegib
  • +3 more
  • Los Angeles, California
  • +8 more
Aug 15, 2017

Idiopathic Pulmonary Fibrosis Trial (, vismodegib)

Withdrawn
  • Idiopathic Pulmonary Fibrosis
  • placebo
  • vismodegib
  • (no location specified)
Nov 1, 2016

Healthy Volunteer Trial in Daytona Beach, Dallas (fluconazole, itraconazole, rabeprazole)

Completed
  • Healthy Volunteer
  • Daytona Beach, Florida
  • +1 more
Nov 1, 2016

Cancer Trial in United States (Vismodegib)

Completed
  • Cancer
  • Vismodegib
  • Chicago, Illinois
  • +4 more
Apr 14, 2016

Adult Medulloblastoma Trial in United States (Pharmacological Study, Vismodegib)

Completed
  • Adult Medulloblastoma
  • Pharmacological Study
  • Vismodegib
  • Los Angeles, California
  • +12 more
Jan 28, 2016

MDS, Myelogenous Leukemia, Acute Trial in Canada, Germany, United States (cytarabine, vismodegib)

Terminated
  • Myelodysplastic Syndromes, Myelogenous Leukemia, Acute
  • Stanford, California
  • +13 more
Nov 11, 2015

Recurrent Childhood Medulloblastoma Trial in United States (Laboratory Biomarker Analysis, Pharmacological Study, Vismodegib)

Completed
  • Recurrent Childhood Medulloblastoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Dec 10, 2015

Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in United States

Completed
  • Adenocarcinoma of the Gastroesophageal Junction
  • +6 more
  • Sacramento, California
  • +29 more
Dec 16, 2015